Ananda Ghosh
Stock Analyst at H.C. Wainwright
(4.09)
# 1,535
Out of 5,133 analysts
150
Total ratings
41.3%
Success rate
10.7%
Average return
Main Sectors:
Stocks Rated by Ananda Ghosh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BIIB Biogen | Reiterated: Buy | $270 | $253.40 | +6.55% | 2 | Nov 13, 2026 | |
| IBIO iBio, Inc. | Reiterated: Buy | $7 | $0.7317 | +856.68% | 3 | Nov 13, 2026 | |
| PRQR ProQR Therapeutics | Reiterated: Buy | $8 | $1.41 | +467.38% | 12 | Nov 13, 2026 | |
| GPCR Structure Therapeutics | Reiterated: Buy | $70 | $20.00 | +250.00% | 22 | Nov 12, 2026 | |
| MDGL Madrigal Pharmaceuticals | Reiterated: Buy | $620 | $427.39 | +45.07% | 2 | Nov 12, 2026 | |
| ANNX Annexon | Reiterated: Buy | $25 | $3.92 | +537.76% | 12 | Nov 10, 2026 | |
| IVA Inventiva | Reiterated: Buy | $14 | $3.68 | +280.43% | 6 | Nov 10, 2026 | |
| MAZE Maze Therapeutics | Reiterated: Buy | $110 | $34.33 | +220.42% | 25 | Nov 10, 2026 | |
| PEPG PepGen | Reiterated: Buy | $20 | $4.36 | +358.72% | 15 | Nov 10, 2026 | |
| WVE Wave Life Sciences | Reiterated: Buy | $13 | $3.13 | +315.34% | 2 | Nov 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $2.54 | +214.96% | 1 | Nov 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 → $32 | $17.16 | +86.48% | 10 | Nov 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $8.16 | +267.65% | 1 | Nov 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $55 | $30.29 | +81.58% | 1 | Nov 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $42 | $18.74 | +124.12% | 1 | Nov 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $641 | $538.60 | +19.01% | 1 | Nov 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 | $26.68 | +87.41% | 12 | Nov 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $37 → $33 | $18.75 | +76.00% | 15 | Sep 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $160 | $1.09 | +14,578.90% | 7 | May 21, 2026 |
Biogen
Nov 13, 2026
Reiterated: Buy
Price Target: $270
Current: $253.40
Upside: +6.55%
iBio, Inc.
Nov 13, 2026
Reiterated: Buy
Price Target: $7
Current: $0.7317
Upside: +856.68%
ProQR Therapeutics
Nov 13, 2026
Reiterated: Buy
Price Target: $8
Current: $1.41
Upside: +467.38%
Structure Therapeutics
Nov 12, 2026
Reiterated: Buy
Price Target: $70
Current: $20.00
Upside: +250.00%
Madrigal Pharmaceuticals
Nov 12, 2026
Reiterated: Buy
Price Target: $620
Current: $427.39
Upside: +45.07%
Annexon
Nov 10, 2026
Reiterated: Buy
Price Target: $25
Current: $3.92
Upside: +537.76%
Inventiva
Nov 10, 2026
Reiterated: Buy
Price Target: $14
Current: $3.68
Upside: +280.43%
Maze Therapeutics
Nov 10, 2026
Reiterated: Buy
Price Target: $110
Current: $34.33
Upside: +220.42%
PepGen
Nov 10, 2026
Reiterated: Buy
Price Target: $20
Current: $4.36
Upside: +358.72%
Wave Life Sciences
Nov 10, 2026
Reiterated: Buy
Price Target: $13
Current: $3.13
Upside: +315.34%
Nov 6, 2026
Reiterated: Buy
Price Target: $8
Current: $2.54
Upside: +214.96%
Nov 6, 2026
Reiterated: Buy
Price Target: $50 → $32
Current: $17.16
Upside: +86.48%
Nov 6, 2026
Reiterated: Buy
Price Target: $30
Current: $8.16
Upside: +267.65%
Nov 5, 2026
Reiterated: Buy
Price Target: $55
Current: $30.29
Upside: +81.58%
Nov 4, 2026
Reiterated: Buy
Price Target: $42
Current: $18.74
Upside: +124.12%
Nov 4, 2026
Reiterated: Buy
Price Target: $641
Current: $538.60
Upside: +19.01%
Nov 2, 2026
Reiterated: Buy
Price Target: $50
Current: $26.68
Upside: +87.41%
Sep 25, 2026
Reiterated: Buy
Price Target: $37 → $33
Current: $18.75
Upside: +76.00%
May 21, 2026
Reiterated: Buy
Price Target: $160
Current: $1.09
Upside: +14,578.90%